Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Pilot Study Comparing 10hz vs Theta Burst Stimulation [Phase 3]
Phase 3 pilot study comparing 10 Hz stimulation to theta burst stimulation in major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Deep Brain Stimulation of the Superolateral Branch of the Medial Forebrain Bundle (slMFB) for the Treatment of Refractory Major Depression [Phase 2]
Phase 2 clinical trial evaluating deep brain stimulation of the slMFB for treatment-refractory major depression has been completed.
-
CLINICAL_TRIALS trial_result · 2018-08-06Clinical Trial Update: Magnetic Seizure Therapy (MST) for Treatment Resistant Major Depression [Phase 3]
Phase 3 clinical trial update on Magnetic Seizure Therapy (MST) for treatment-resistant major depression completed.
-
CLINICAL_TRIALS research · 2018-08-01Clinical Trial Update: Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels [NA]
This clinical trial investigates whether noninvasive brain stimulation alters brain-derived neurotrophic factor (BDNF) levels in individuals…
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Ketamine Plus Lithium in Treatment-Resistant Depression [Phase 2]
A Phase 2 clinical trial evaluating ketamine in combination with lithium for treatment-resistant depression has completed and posted results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Bio-psycho-social Pathways Underlying the Effects of Qigong Among Comorbid Depressed Elderly With Chronic Conditions [NA]
This completed clinical trial from The Hong Kong Polytechnic University evaluated the bio-psycho-social pathways underlying the effects of q…
-
CLINICAL_TRIALS research · 2018-07-31Clinical Trial Update: Transcranial Magnetic Stimulation Study of Cortical Excitability as Marker of Antidepressant Response: EXCIPSY Study [NA]
Update on the EXCIPSY trial evaluating transcranial magnetic stimulation as a marker of antidepressant response in Major Depressive Disorder…
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Mindfulness Intervention to Study the Neurobiology of Depression [NA]
A completed clinical trial evaluating a mindfulness intervention to study the neurobiology of depression has posted results.
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Bipolarity - Depression in Children and Adolescent Suicide Attempters: Better Diagnosis to Prevent Recurrence [NA]
A completed clinical trial sponsored by Fondation Lenval evaluating improved diagnostic approaches to prevent recurrence of suicidal behavio…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: The Treatment of Depression With Botulinum Type A Toxin [Phase 2]
Phase 2 trial evaluating botulinum toxin type A for treatment of depression completed; results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine [Phase 1, Phase 2]
A Phase 1/2 clinical trial assesses whether buprenorphine can help achieve remission in late-life major depressive disorder/depression after…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Sleep Therapy for Insomnia and Depression [NA]
A University of Michigan sponsor completed a clinical trial evaluating sleep therapy for individuals with co-occurring insomnia and depressi…
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Canadian rTMS Treatment and Biomarker Network in Depression Trial [NA]
A completed Canadian trial evaluating repetitive transcranial magnetic stimulation (rTMS) treatment and a biomarker network for depression.
-
FDA approval · 2018-07-23FDA Approved: BUPROPION — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Bupropion from Zydus Pharmaceuticals USA Inc., indicating an approved update to an existing Bupr…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Bipolar Depression [NA]
A pilot study evaluated repetitive transcranial magnetic stimulation (rTMS) as a treatment for bipolar depression. The trial has completed a…
-
CLINICAL_TRIALS research · 2018-07-23Clinical Trial Update: Probing Prefrontal Cortex Hemodynamic Alterations for Major Depression Disorder
This clinical trials update describes ongoing research into prefrontal cortex hemodynamics in individuals with major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Improving Health and Reducing Disability of Depressed Elderly With Chronic Conditions Through Qigong Exercise [NA]
A completed clinical trial evaluating Qigong exercise to improve health and reduce disability in elderly people with depressive symptoms and…
-
FDA approval · 2018-07-19FDA Approved: DULOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental ANDA for a generic duloxetine product (ANDA204343). Duloxetine is indicated for major depr…
-
CLINICAL_TRIALS research · 2018-07-19Clinical Trial Update: Neural Alteration Response to Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Depressed Patients [NA]
Clinical trial update on transcutaneous auricular vagus nerve stimulation (taVNS) for depression, focusing on neural responses in patients; …
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Bupropion for Depression in ESRD Patients on Hemodialysis [Phase 4]
Phase 4 study of bupropion for major depressive disorder in patients with end-stage renal disease on hemodialysis was terminated, with resul…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression
A completed clinical trial update reports results on using quantified mobile sensing to improve diagnosis and measure disease progression in…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts.
This completed clinical trial evaluated a combination of Rhodiola rosea extract and saffron extract for managing mild to moderate depression…
-
CLINICAL_TRIALS research · 2018-07-17Clinical Trial Update: fMRI Studies of Emotional Brain Circuitry in People With Major Depression [NA]
This clinical trial update reports completed fMRI studies examining emotional brain circuitry in people with major depressive disorder, with…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Primary Care Group Therapy for Depression/Anxiety for Women in Petropolis [Phase 3]
A Phase 3 clinical trial evaluating primary care group therapy for depression and anxiety in women in Petropolis has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Berlin Magnetic Seizure Therapy Depression Trial 01 [Phase 3]
A Phase 3 clinical trial of Berlin Magnetic Seizure Therapy for major depressive disorder and bipolar disorder has completed.